<style face="normal" font="default" size="100%">Pharmacogenetics of treatments for inflammatory bowel disease.</style>

Drupal-Biblio

17

<style face="normal" font="default" size="100%">Pharmacogenetics of treatments for inflammatory bowel disease.</style>

Drupal-Biblio

17

<style face="normal" font="default" size="100%">Epratuzumab and Blinatumomab as Therapeutic Antibodies for Treatment of Pediatric Acute Lymphoblastic Leukemia: Current Status and Future Perspectives.</style>

Drupal-Biblio

17

<style face="normal" font="default" size="100%">Multicentric Case-Control Study on Azathioprine Dose and Pharmacokinetics in Early-onset Pediatric Inflammatory Bowel Disease.</style>

Drupal-Biblio

17

<style face="normal" font="default" size="100%">Glucocorticoid pharmacogenetics in pediatric idiopathic nephrotic syndrome.</style>

Drupal-Biblio

17

<style face="normal" font="default" size="100%">Role of Pharmacogenetics in Hematopoietic Stem Cell Transplantation Outcome in Children.</style>

Drupal-Biblio

17

<style face="normal" font="default" size="100%">Pharmacogenetics of azathioprine in inflammatory bowel disease: a role for glutathione-S-transferase?</style>

Drupal-Biblio

17

<style face="normal" font="default" size="100%">TNF-α SNP rs1800629 and risk of relapse in childhood acute lymphoblastic leukemia: relation to immunophenotype.</style>

Drupal-Biblio

17

<style face="normal" font="default" size="100%">Personalized therapies in pediatric inflammatory and autoimmune diseases.</style>

Drupal-Biblio

17

<style face="normal" font="default" size="100%">Molecular mechanism of glucocorticoid resistance in inflammatory bowel disease.</style>